Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/AZ/Tucson
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Tucson, AZ

Studies commonly pay $75 to $4,500 per completed study

479 clinical trials are currently recruiting participants within 30 miles of Tucson. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

479studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Tucson right now

Top 25 of 479 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
The University of Arizona Cancer Center - North Campus — Tucson, Arizona (5.4 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma

HER2/Neu+ Uterine Serous Carcinoma Phase 2 Interventional 50 participants sought
University of Arizona Cancer Center — Tucson, Arizona (5.4 mi) · Sponsor: Yale University
See eligibility & contact on ClinicalTrials.gov (NCT02491099)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Tucson, Arizona (5.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Atopic Dermatitis N/A Observational 1,000 participants sought
Galderma Investigational Site - 7067 — Tucson, Arizona (5.4 mi) · Sponsor: Galderma R&D
See eligibility & contact on ClinicalTrials.gov (NCT06988605)

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Atrial Fibrillation N/A Interventional 276 participants sought
Tucson Medical Center Pima Heart and Vascular — Tucson, Arizona (5.4 mi) · Sponsor: Biosense Webster, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07227532)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension Phase 2 Interventional 280 participants sought
Retension Clinical Site — Tucson, Arizona (5.4 mi) · Sponsor: Retension Pharmaceuticals. Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07142356)

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease N/A Observational 3,000 participants sought
University of Arizona — Tucson, Arizona (5.4 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT01915511)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05624996)

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Relapsed Refractory Multiple Myeloma Phase 3 Interventional 508 participants sought
Research Site — Tucson, Arizona (5.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07391657)

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer Phase 2 Interventional 310 participants sought
Site 0102 - University of Arizona Cancer Center — Tucson, Arizona (5.4 mi) · Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
See eligibility & contact on ClinicalTrials.gov (NCT05128825)

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Non-muscle-invasive Bladder Cancer Phase 1, Phase 2 Interventional 75 participants sought
Arizona Urology Specialists — Tucson, Arizona (5.4 mi) · Sponsor: SURGE Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT05710848)

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Cardiovascular Disease and Lipoprotein(a) Phase 3 Interventional 5,700 participants sought
Eclipse Clinical Research — Tucson, Arizona (5.4 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07517263)

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

Psoriatic Arthritis Phase 3 Interventional 600 participants sought
Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ — Tucson, Arizona (5.4 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT06671496)

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Epithelial Ovarian Cancer, Primary Peritoneal Phase 2 Interventional 230 participants sought
SCRI - Arizona Oncology Associates, PC-HOPE — Tucson, Arizona (5.4 mi) · Sponsor: TORL Biotherapeutics, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06690775)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Geographic Atrophy, Macular Degeneration Phase 2 Interventional 274 participants sought
Retina Associates Southwest PC — Tucson, Arizona (5.4 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06635148)
Actively enrolling

Studies you may be able to join near Tucson

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Tucson

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Arizona Clinical Research Center

★ 5.0
1825 N Kolb Rd, Tucson, AZ 85715
(520) 290-2510

Quality of Life Research Center

★ 5.0
6390 E Broadway Blvd, Tucson, AZ 85710
(520) 731-2333
"Awesome place. Caring staff and get you in and out quickly."
— Elijah Silverman, 5★

M3 Wake Research Tucson

★ 4.4
6567 E Carondelet Dr, Tucson, AZ 85710
(520) 230-1373
"The staff here are wonderful and friendly and nice. It’s the only place I can think of where I go, get blood drawn and come out smiling. I hope to be…"
— Gina Murphy-Darling, 5★

Arizona Clinical Trials

★ 4.0
1601 N Swan Rd Bldg B, Tucson, AZ 85712
(520) 445-4000
"A really impressive organization. The trials are competently run, and the providers are both professional and compassionate. I’m so lucky to have…"
— My Reviews, 5★

Arizona Clinical Trials

★ 4.0
3900 E Broadway Blvd, Tucson, AZ 85711
(520) 636-5000
"These people just called me and basically said if I need to reschedule my appointment immediately this week. This was so the staff can have a two wee…"
— Leslie Baird, 2★

Tucson Clinical Research Institute

★ 4.6
6290 E Grant Rd, Tucson, AZ 85712
(520) 367-5032
"I've been going there about 9 months with my COPD, and the Staff takes excellent care of me. Lance Kunkel is the Director of Operations, and the rest…"
— James Ferguson, 5★

Noble Clinical Research

★ 4.6
2055 W Hospital Dr #175, Tucson, AZ 85704
(520) 612-7860
"I came in genuinely seeking help for major depressive disorder. I’m low-income, on AHCCCS, and have been struggling with depression for years. I drov…"
— Shar, 1★

Eclipse Clinical Research

★ 4.6
1775 W St Marys Rd #211, Tucson, AZ 85745
(520) 647-9926
"Friendly staff, quick and efficient service"
— Jonathan Pringle, 4★

Del Sol Research Management

★ 4.7
6369 E Tanque Verde Rd Unit 200, Tucson, AZ 85715
(520) 257-3881
"staff are hardworking and professional. I dislike public bathrooms and now I know why. The bathroom was dirty to my standards. The building wasn’t…"
— Luz Bates, 5★

Clinical trials in Tucson: what's recruiting

The Tucson area currently has 479 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Tucson, the most active research areas are:

  • Cancer & Oncology14 studies
  • Immune & Skin2 studies
  • Heart & Vascular2 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Tucson, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Tucson

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Tucson participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Tucson?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Tucson, AZ?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Tucson?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Tucson typically complete one or two studies per year.

Paid clinical trials near Tucson

Other metros within reach

Gilbert, AZ1,369 Chandler, AZ1,369 Mesa, AZ1,367 Tempe, AZ1,433 Scottsdale, AZ1,400 Phoenix, AZ1,433 Glendale, AZ1,433 Peoria, AZ1,257

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Tucson Bladder Issues Due To Spinal Cord Injury in Tucson All conditions

More of AZ

Phoenix1,433 Glendale1,433 Tempe1,433 Scottsdale1,400 Gilbert1,369 Chandler1,369 Mesa1,367 Peoria1,257 Surprise986 Yuma10

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts